Mackenzie Financial
CRNX icon

Mackenzie Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History

Mackenzie Financial’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,666
Closed -$268K – 1495
2025
Q4 		$268K Sell
5,666
-273
-5% -$12.2K ﹤0.01% 1428
2025
Q3 		$247K Buy
+5,939
New +$190K ﹤0.01% 1479
2025
Q1 		– Sell
-5,422
Closed -$277K – 1710
2024
Q4 		$277K Buy
5,422
+440
+9% +$24.6K ﹤0.01% 1418
2024
Q3 		$255K Buy
+4,982
New +$257K ﹤0.01% 1263
2023
Q3 		– Sell
-14,909
Closed -$269K – 1495
2023
Q2 		$269K Buy
+14,909
New +$297K ﹤0.01% 1207

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return